2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation

Overview

Journal J Low Genit Tract Dis

Specialty Gynecology & Obstetrics

Date 2020 Apr 4

PMID 32243306

Citations 49

Authors

Li C Cheung

Didem Egemen

Xiaojian Chen

Hormuzd A Katki

Maria Demarco

Amy L Wiser

Rebecca B Perkins

Richard S Guido

Nicolas Wentzensen

Mark Schiffman

Affiliations

Soon will be listed here.

Abstract

Objective: To manage cervical screening abnormalities, the 2019 ASCCP management consensus guidelines will recommend clinical action on the basis of risk of cervical precancer and cancer. This article details the methods used to estimate risk, to determine the risk-based management, and to validate that the risk-based recommendations are of general use in different settings.

Methods: Based on 1.5 million patients undergoing triennial cervical screening by cotesting at the Kaiser Permanente Northern California from 2003 to 2017, we estimated risk profiles for different clinical scenarios and combinations of past and current human papillomavirus and cytology test results. We validated the recommended management by comparing with the estimated risks in several external data sources.

Results: Risk and management tables are presented separately by Egemen et al. and Demarco et al. Risk-based management derived from the Kaiser Permanente Northern California largely agreed with the management implied from the estimated risks of the other data sources.

Conclusions: The new risk-based guidelines present management of abnormal cervical screening results. By describing the steps used to develop these guidelines, the methods presented in this article can provide a basis for future extensions of the risk-based guidelines.

Citing Articles

Long-Term Reassurance with Negative High-Risk Human Papillomavirus (HR-HPV) and Clear Margins After Large Loop Excision of the Transformation Zone (LLETZ).

Heydari F, de Sanjose S, Penafiel Munoz J, Fernandez-Montoli M Cancers (Basel). 2025; 17(3).

PMID: 39941854 PMC: 11816363. DOI: 10.3390/cancers17030487.

Development, validation, and clinical application of a machine learning model for risk stratification and management of cervical cancer screening based on full-genotyping hrHPV test (SMART-HPV): a modelling study.

Dong B, Lu Z, Yang T, Wang J, Zhang Y, Tuo X Lancet Reg Health West Pac. 2025; 55:101480.

PMID: 39926367 PMC: 11802380. DOI: 10.1016/j.lanwpc.2025.101480.

Evaluating the Use of Environmental and Polygenic Risk Scores to Inform Colorectal Cancer Risk-Based Surveillance Intervals.

Landy R, Katki H, Huang W, Wang D, Thomas M, Qu F Clin Transl Gastroenterol. 2024; 15(12):e00782.

PMID: 39733276 PMC: 11671055. DOI: 10.14309/ctg.0000000000000782.

Assessment of a colposcopic scoring system (Swedescore) to reduce the number of cervical biopsies: a protocol for a clinical multicentre non-randomised intervention study in Denmark.

Knudsen A, Randrup T, Kesmodel U, Booth B, Gustafson L, Trope A BMJ Open. 2024; 14(12):e085382.

PMID: 39675832 PMC: 11647325. DOI: 10.1136/bmjopen-2024-085382.

Detecting and localizing cervical lesions in colposcopic images with deep semantic feature mining.

Wang L, Chen R, Weng J, Li H, Ying S, Zhang J Front Oncol. 2024; 14:1423782.

PMID: 39664173 PMC: 11633668. DOI: 10.3389/fonc.2024.1423782.

References

Katki H, Kinney W, Fetterman B, Lorey T, Poitras N, Cheung L . Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 2011; 12(7):663-72. PMC: 3272857. DOI: 10.1016/S1470-2045(11)70145-0. View

McCredie M, Sharples K, Paul C, Baranyai J, Medley G, Jones R . Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008; 9(5):425-34. DOI: 10.1016/S1470-2045(08)70103-7. View

Egemen D, Cheung L, Chen X, Demarco M, Perkins R, Kinney W . Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. J Low Genit Tract Dis. 2020; 24(2):132-143. PMC: 7147417. DOI: 10.1097/LGT.0000000000000529. View

Perkins R, Guido R, Castle P, Chelmow D, Einstein M, Garcia F . 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020; 24(2):102-131. PMC: 7147428. DOI: 10.1097/LGT.0000000000000525. View

Landy R, Cheung L, Schiffman M, Gage J, Hyun N, Wentzensen N . Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records. Prev Med. 2017; 111:429-435. PMC: 5930038. DOI: 10.1016/j.ypmed.2017.12.004. View

Cheung L, Pan Q, Hyun N, Schiffman M, Fetterman B, Castle P . Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records. Stat Med. 2017; 36(22):3583-3595. PMC: 5583012. DOI: 10.1002/sim.7380. View

Castle P, Xie X, Xue X, Poitras N, Lorey T, Kinney W . Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results. Prev Med. 2018; 118:44-50. DOI: 10.1016/j.ypmed.2018.10.001. View

Castle P, Kinney W, Cheung L, Gage J, Fetterman B, Poitras N . Why does cervical cancer occur in a state-of-the-art screening program?. Gynecol Oncol. 2017; 146(3):546-553. PMC: 5743197. DOI: 10.1016/j.ygyno.2017.06.003. View

Wright Jr T, Cox J, Massad L, Twiggs L, Wilkinson E . 2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities. J Low Genit Tract Dis. 2006; 6(2):127-43. DOI: 10.1097/00128360-200204000-00012. View

10.

Stoler M, Wright Jr T, Parvu V, Vaughan L, Yanson K, Eckert K . The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results. Gynecol Oncol. 2018; 149(3):498-505. DOI: 10.1016/j.ygyno.2018.04.007. View

11.

Gage J, Hunt W, Schiffman M, Katki H, Cheung L, Myers O . Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines. Obstet Gynecol. 2016; 128(6):1248-1257. PMC: 5247269. DOI: 10.1097/AOG.0000000000001721. View

12.

Wright Jr T, Stoler M, Behrens C, Apple R, Derion T, Wright T . The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol. 2011; 206(1):46.e1-46.e11. DOI: 10.1016/j.ajog.2011.07.024. View

13.

Castle P, Solomon D, Wheeler C, Gravitt P, Wacholder S, Schiffman M . Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol. 2008; 46(8):2595-604. PMC: 2519476. DOI: 10.1128/JCM.00824-08. View

14.

Lee N, Wong F, Jamison P, Jones S, Galaska L, Brady K . Implementation of the National Breast and Cervical Cancer Early Detection Program: the beginning. Cancer. 2014; 120 Suppl 16:2540-8. PMC: 4481738. DOI: 10.1002/cncr.28820. View

15.

Wright Jr T, Massad L, Dunton C, Spitzer M, Wilkinson E, Solomon D . 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis. 2007; 11(4):201-22. DOI: 10.1097/LGT.0b013e3181585870. View

16.

Massad L, Einstein M, Huh W, Katki H, Kinney W, Schiffman M . 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013; 17(5 Suppl 1):S1-S27. DOI: 10.1097/LGT.0b013e318287d329. View

17.

Manos M, Kinney W, Hurley L, Sherman M, Kurman R, Ransley J . Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999; 281(17):1605-10. DOI: 10.1001/jama.281.17.1605. View

18.

Castle P, Shaber R, Lamere B, Kinney W, Fetterma B, Poitras N . Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California. Cancer Epidemiol Biomarkers Prev. 2011; 20(5):946-53. PMC: 3117227. DOI: 10.1158/1055-9965.EPI-10-1267. View

19.

Kardos T . The FocalPoint System: FocalPoint slide profiler and FocalPoint GS. Cancer. 2004; 102(6):334-9. DOI: 10.1002/cncr.20720. View

20.

Schiffman M, Hyun N, Raine-Bennett T, Katki H, Fetterman B, Gage J . A cohort study of cervical screening using partial HPV typing and cytology triage. Int J Cancer. 2016; 139(11):2606-15. DOI: 10.1002/ijc.30375. View